Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-01 Purchase | 2023-08-03 8:01 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 833,333 | $4.8 | $3,999,998 | 1,571,741 (Indirect) | View |
2023-05-11 Purchase | 2023-05-15 5:06 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 447,932 | $6.3626 | $2,849,998 | 3,661,518 (Indirect) | View |
2023-03-29 Purchase | 2023-03-30 5:46 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 344,592 | $4.5379 | $1,563,724 | 3,213,586 (Indirect) | View |
2023-03-27 Purchase | 2023-03-29 7:30 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 207,840 | $4.0467 | $841,063 | 2,868,994 (Indirect) | View |
2022-04-19 Purchase | 2022-04-20 4:05 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 1,070,000 | $3.69 | $3,948,300 | 2,661,154 (Indirect) | View |
2021-08-02 Purchase | 2021-08-04 5:52 pm | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 576,923 | $13 | $7,499,999 | 3,975,239 (Indirect Direct) | View |
2021-02-08 Sale | 2021-02-10 7:22 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 378,698 | $27.34 | $10,355,466 | 1,405,418 (Indirect) | View |
2021-02-02 Sale | 2021-02-04 8:51 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 17,002 | $25.12 | $427,067 | 1,784,116 (Indirect) | View |
2021-01-28 Sale | 2021-02-02 12:17 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 2,000 | $25.07 | $50,140 | 1,801,118 (Indirect) | View |
2021-01-25 Sale | 2021-01-27 6:02 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 55,254 | $25.62 | $1,415,845 | 1,803,118 (Indirect) | View |
2021-01-20 Sale | 2021-01-22 6:10 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 30,529 | $25.28 | $771,723 | 1,858,372 (Indirect) | View |
2021-01-14 Sale | 2021-01-19 9:07 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 91,111 | $25.71 | $2,342,558 | 1,888,901 (Indirect) | View |
2021-01-11 Sale | 2021-01-13 8:39 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 97,343 | $26.29 | $2,558,948 | 1,980,012 (Indirect) | View |
2021-01-06 Sale | 2021-01-08 5:17 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 145,612 | $28.3 | $4,120,277 | 2,077,355 (Indirect) | View |
2020-07-28 Purchase | 2020-07-28 6:11 pm | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director 10% Owner | 187,500 | $16 | $3,000,000 | 1,591,154 (Indirect) | View |
2020-06-16 Purchase | 2020-06-16 7:21 pm | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 93,000 | $16 | $1,488,000 | 2,222,967 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-18 Option Award | 2024-06-20 4:15 pm | N/A 2034-06-17 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 28,000 | $0 | 28,000 (Direct) | View |
2024-05-15 Option Award | 2024-05-17 5:03 pm | N/A 2034-05-15 | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 16,500 | $0 | 16,500 (Direct) | View |
2023-06-13 Option Award | 2023-06-15 4:05 pm | N/A 2033-06-12 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 16,000 | $0 | 16,000 (Direct) | View |
2023-05-17 Option Award | 2023-05-19 5:24 pm | N/A 2033-05-17 | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 15,490 | $0 | 15,490 (Direct) | View |
2022-06-10 Option Award | 2022-06-14 07:49 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 9,367 | $0 | 9,367 (Direct) | View |
2022-05-24 Option Award | 2022-05-26 8:09 pm | N/A 2032-05-24 | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 13,440 | $0 | 13,440 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 8:44 pm | N/A 2032-01-03 | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 6,242 | $0 | 6,242 (Direct) | View |
2021-07-28 Other | 2021-08-04 5:52 pm | N/A N/A | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 12,483,581 | $0 | 3,975,239 (Indirect) | View |
2021-07-28 Option Award | 2021-08-04 5:52 pm | N/A N/A | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 13,440 | $0 | 3,975,239 (Direct) | View |
Ownership | 2021-07-29 7:35 pm | N/A N/A | Rallybio Corp | RLYB | Hopfner Robert Lorne Director | 0 | $0 | 1,707,828 (Indirect) | View |
2021-06-23 Option Award | 2021-06-24 4:12 pm | N/A 2031-06-22 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 9,367 | $0 | 9,367 (Direct) | View |
2021-06-02 Option Award | 2021-06-03 6:51 pm | N/A 2031-06-01 | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 15,000 | $0 | 15,000 (Direct) | View |
2020-07-28 Conversion | 2020-07-28 6:11 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director 10% Owner | 11,893,164 | $0 | 1,591,154 (Indirect) | View |
2020-07-23 Option Award | 2020-07-24 4:47 pm | N/A 2030-07-22 | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director | 9,367 | $0 | 9,367 (Direct) | View |
Ownership | 2020-07-23 9:33 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Hopfner Robert Lorne Director 10% Owner | 0 | $0 | 1,403,654 (Indirect) | View |
2020-06-16 Conversion | 2020-06-16 7:21 pm | N/A N/A | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 2,129,967 | $0 | 2,222,967 (Indirect) | View |
2020-06-11 Option Award | 2020-06-15 6:14 pm | N/A 2030-06-10 | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2020-06-11 7:51 pm | N/A N/A | Vaxcyte Inc. | PCVX | Hopfner Robert Lorne Director | 0 | $0 | 2,129,967 (Indirect) | View |